Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT01306838

Early Provision of Enteral Microlipid and Fish Oil to Infants With Enterostomy (EMLFO)

Early Supplementation of Enteral Lipid With Combination of Microlipid and Fish Oil in Infants With Enterostomy

Sponsor: Wake Forest University

Conditions Necrotizing Enterocolitis Short Bowel Syndrome Small Intestine Perforation

Interventions MicroLipid and fish oil Routine care

Updated 8 times since 2017 Last updated: Aug 13, 2018 Started: Oct 31, 2009 Primary completion: Oct 31, 2014 Completion: Oct 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01306838, this EARLY_PHASE1 trial focuses on Necrotizing Enterocolitis and Short Bowel Syndrome and remains completed. Sponsored by Wake Forest University, it has been updated 8 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Sep 2018 — Jan 2021 [monthly]

Completed EARLY_PHASE1

Phase: NA → EARLY_PHASE1
Jun 2018 — Sep 2018 [monthly]

Completed NA

▶ Show 3 earlier versions

Dec 2017 — Jun 2018 [monthly]

Completed NA
Apr 2017 — Dec 2017 [monthly]

Completed NA

Status: Unknown Status → Completed · Phase: PHASE3 → NA
Jan 2017 — Apr 2017 [monthly]

Unknown Status PHASE3

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Wake Forest University

Data source: Wake Forest University Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Winston-Salem, United States